Form 4: Surgery Partners CFO David Doherty Acquires Shares Through Restricted Stock Award

David T. Doherty, CFO of Surgery Partners, Inc., acquired 25,657 shares of common stock through a restricted stock award on February 28, 2024.

Summary

• On February 28, 2024, David T. Doherty, the Chief Financial Officer of Surgery Partners, Inc., acquired 25,657 shares of common stock.
• The acquisition was part of a restricted stock award (RSA) granted to Doherty.
• The price of the stock at the time of the transaction was $31.18 per share.
• The RSAs vest in three equal annual installments starting on the first anniversary of the grant date.
• Following the transaction, Doherty directly owns 99,866 shares of Surgery Partners, Inc.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by the CFO suggests confidence in the company's performance, but it's a routine transaction.

Positives

• The acquisition of shares by the CFO demonstrates confidence in the company's future prospects.

Future Outlook

The restricted stock awards vest in three equal annual installments, suggesting a long-term commitment from the CFO.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates changes in the beneficial ownership of company stock by a key executive.

Comparison to Industry Standards

• Restricted stock awards are a common form of executive compensation in the healthcare industry, aligning management's interests with those of shareholders.
• Comparing the vesting schedule and the number of shares granted to similar companies like AmSurg or Envision Healthcare would provide a benchmark for the size and structure of this RSA.

Stakeholder Impact

• The acquisition of shares by the CFO could be viewed positively by shareholders, as it aligns management's interests with theirs.

Key Dates